EUVIMEDEUVIMED entdecken
Kohortenstudie

Novel metabolic and inflammatory stratification of overweight/obesity to characterize risks of adverse outcomes: A large population‐based cohort study

Hang Dong, Yingzhou Shi, Yicheng Ma, Yiping Cheng, Luna Liu, Shengyang Xiao, Zinuo Yuan, Zhen Wang, Tuo Li, Jiajun Zhao iD, Xiude Fan iD

Diabetes, Obesity and Metabolism · 2025

DOI: 10.1111/dom.16262 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Diabetes, Obesity and Metabolism, 2025. Verfasst von Hang Dong und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Endocrinology, Shandong Provincial Hospital, Shandong University; Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Agi…. Hauptthemen laut MEDLINE: Obesity, Overweight, Inflammation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 52 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China - Regional Innovation and Development Joint Fund, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

The growing epidemic of overweight and obesity elevates disease risks, with metabolic disorders and inflammation critically involved in the pathogenic mechanisms. This study refines the subtyping of overweight and obesity using metabolic and inflammatory markers to enhance risk assessment and personalized prevention. Materials and Methods Based on the UK Biobank, this retrospective study included participants classified as overweight or obese (BMI ≥25 kg/m 2 ). K‐means clustering was performed using metabolic and inflammatory biomarkers. Multivariate Cox regression analysis assessed the risk of complications and mortality over a follow‐up period of 13.5 years. Genome‐Wide Association Studies (GWAS) and Phenome‐Wide Association Studies (PheWAS) explored cluster‐specific genetic traits.

Results

Among 126 145 participants (mean [IQR] age: 55.0 [14.0] years; 61 983 males [49.1%]), five clusters were identified: (1) Low Metabolic Risk‐related, (2) Hypertension‐Related, (3) Mixed Hyperlipidemia‐Related, (4) Elevated Lipoprotein(a)‐Related and (5) High BMI and Inflammation‐Related. Cluster 1 exhibited a lower risk of complications than other clusters. Cluster 2 had the highest incidence of stroke, linked to variants affecting blood circulation. Cluster 3 showed the highest risks for ischaemic heart disease, characterized by variants enriched in cholesterol metabolism pathways. Cluster 4 was associated with high cardiovascular risks. Cluster 5 had the highest risks for diabetes, asthma, chronic obstructive pulmonary disease, osteoarthritis and mortality, linked to obesity‐related genetic variants. We also proposed a method for applying this classification in clinical settings.

Conclusions

This classification provides insights into the heterogeneity of individuals with overweight and obesity, aiding in the identification of high‐risk patients who may benefit from targeted interventions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ObesityOverweightInflammationHumansMaleFemaleMiddle AgedRetrospective StudiesAdultAgedUnited KingdomRisk FactorsRisk AssessmentGenome-Wide Association StudyBiomarkersBody Mass Index

Stichwörter der Autor:innen

clustermetabolic factorobesityoverweightprognosisrisk stratification

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Department of Endocrinology, Shandong Provincial Hospital, Shandong University; Key Laboratory of Endocrine Glucose & Lipids Metabolism and Brain Aging, Ministry of Education, Jinan, Shandong, China.
  • Shandong Clinical Research Center of Diabetes and Metabolic Diseases, Jinan, Shandong, China.
  • Shandong Institute of Endocrine and Metabolic Diseases, Jinan, Shandong, China.
  • "Chuangxin China" Innovation Base of Stem Cell and Gene Therapy for Endocrine Metabolic Diseases, Jinan, Shandong, China.
  • Shandong Engineering Laboratory of Prevention and Control for Endocrine and Metabolic Diseases, Jinan, Shandong, China.
  • Shandong Engineering Research Center of Stem Cell and Gene Therapy for Endocrine and Metabolic Diseases, Jinan, Shandong, China.

ORCID-Profile: Jiajun Zhao, Xiude Fan

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China - Regional Innovation and Development Joint Fund
  • National Natural Science Foundation of China
  • Natural Science Foundation of Shandong Province

Zitieren

APA

Dong, H., Shi, Y., Ma, Y., Cheng, Y., Liu, L., Xiao, S., Yuan, Z., Wang, Z., Li, T., Zhao, J., & Fan, X. (2025). Novel metabolic and inflammatory stratification of overweight/obesity to characterize risks of adverse outcomes: A large population‐based cohort study. Diabetes, Obesity and Metabolism. https://doi.org/10.1111/dom.16262

Vancouver

Dong H, Shi Y, Ma Y, Cheng Y, Liu L, Xiao S, et al. Novel metabolic and inflammatory stratification of overweight/obesity to characterize risks of adverse outcomes: A large population‐based cohort study. Diabetes, Obesity and Metabolism. 2025. doi:10.1111/dom.16262

BibTeX
@article{Dong2025,
  author = {Dong, Hang and Shi, Yingzhou and Ma, Yicheng and Cheng, Yiping and Liu, Luna and Xiao, Shengyang and Yuan, Zinuo and Wang, Zhen and Li, Tuo and Zhao, Jiajun and Fan, Xiude},
  title = {Novel metabolic and inflammatory stratification of overweight/obesity to characterize risks of adverse outcomes: A large population‐based cohort study},
  journal = {Diabetes, Obesity and Metabolism},
  year = {2025},
  doi = {10.1111/dom.16262}
}
Kostenlos starten →